A portion of the US holdings for this investor are reported in this report and a portion are reported by other reporting manager(s). Top holdings included HOOD, NU, CVNA, VMEO, and COMP.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Ashwin Budhiraja
Chief Financial Officer
New York, New York
18 Nov 2022
This Amendment is being filed solely for the purpose of removing from the Form 13F Information Table certain shares of Class A Common Stock of Oscar Health, Inc. ("Class A Common") inadvertently included in the Form 13F filed by the Reporting Person for the quarter ended March 31, 2022. As of March 31, 2022, the Reporting Person or its affiliates exercised investment discretion over 32,859,064 shares of Class B Common Stock of Oscar Health, Inc. ("Class B Common"). While shares of Class A Common are Section 13(f) securities as defined in Rule 13f-1(c) under the Securities and Exchange Act of 1934, shares of Class B Common are not Section 13(f) securities and thus not reportable. For the avoidance of doubt, this Amendment is to correct a clerical error only, and there were no sales by the Reporting Person of shares of Class A Common or Class B Common during the quarter ended March 31, 2022.
List of Other Managers Reporting for Thrive Capital Management, LLC:
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.